The Scientific World Journal
Volume 2015 (2015), Article ID 612642, 8 pages
http://dx.doi.org/10.1155/2015/612642

Clinical Study

Evidence for Negative Effects of Elevated Intra-Abdominal Pressure on Pulmonary Mechanics and Oxidative Stress

I. Davarcı,¹ M. Karcıoğlu,¹ K. Tuzcu,¹ K. İnanoğlu,¹ T. D. Yetim,² S. Motor,³ K. T. Ulutaş,³ and R. Yüksel³

¹Department of Anesthesiology, Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey
²Department of Thoracic Surgery, Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey
³Department of Biochemistry, Faculty of Medicine, Mustafa Kemal University, Hatay, Turkey

Received 21 July 2014; Accepted 29 December 2014

Academic Editor: Daiana Avila

Copyright © 2015 I. Davarcı et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Objective. To compare the effects of pneumoperitoneum on lung mechanics, end-tidal CO₂ (ETCO₂), arterial blood gases (ABG), and oxidative stress markers in blood and bronchoalveolar lavage fluid (BALF) during laparoscopic cholecystectomy (LC) by using lung-protective ventilation strategy. Materials and Methods. Forty-six patients undergoing LC and abdominal wall hernia (AWH) surgery were assigned into 2 groups. Measurements and blood samples were obtained before, during pneumoperitoneum, and at the end of surgery. BALF samples were obtained after anesthesia induction and at the end of surgery. Results. Peak inspiratory pressure, ETCO₂, and pCO₂ values at the 30th minute were significantly increased, while there was a significant decrease in dynamic lung compliance, pH, and pO₂ values in LC group. In BALF samples, total oxidant status (TOS), arylesterase, paraoxonase, and malondialdehyde levels were significantly increased; the glutathione peroxidase levels were significantly decreased in LC group. The serum levels of TOS and paraoxonase were significantly higher at the end of surgery in LC group. In addition, arylesterase level in the 30th minute was increased compared to baseline. Serum paraoxonase level at the end of surgery was significantly increased when compared to AWH group. Conclusions. Our study showed negative effects of pneumoperitoneum in both lung and systemic levels despite lung-protective ventilation strategy.

1. Introduction

The increasing number of indications of laparoscopic surgery, which is the gold standard approach in several diagnostic and therapeutic procedures, means that anesthesiologists need to have a better understanding of the physiological effects and potential complications of pneumoperitoneum [1]. Laparoscopic surgery, a minimal invasive technique, has substantial effects on the hemodynamic and respiratory system, even in healthy individuals, although it has many advantages compared to conventional open surgical techniques. These pathophysiological effects result in an increased risk of perioperative and postoperative complications in elderly patients with impaired cardiac and pulmonary functions [2, 3].

During laparoscopy, increasing intra-abdominal pressure (IAP) with abdominal CO₂ insufflation causes ischemia through splanchnic vasoconstriction and subsequent reperfusion injury through deflation [2]. Moreover, hypercarbia and acidosis can occur because of ventilation-perfusion mismatch caused by impaired gas exchange due to increased IAP or absorption of insufflated CO₂. Hypercarbia and acidosis affect serum oxidative stress markers and lead to altered hemodynamics [4, 5].

In this prospective study, we evaluated the effects of pneumoperitoneum at an IAP level (<12 mmHg) accepted to be clinically safe on lung mechanics, end-tidal CO₂ (ETCO₂), arterial blood gases, and oxidative stress markers in blood and bronchoalveolar lavage fluid (BALF) during laparoscopic cholecystectomy (LC) using a lung-protective ventilation strategy.

2. Methods

The study was approved by the Local Human Research Board of Mustafa Kemal University, Medicine School. All the patients gave written informed consent before participation in the study. Forty-six patients aged 18–65 years with ASA physical statuses I-II who were scheduled for laparoscopic cholecystectomy and abdominal wall hernia (AWH) surgery were assigned to 2 groups, with 23 patients in each group. Patients with cardiac, pulmonary, renal, hepatic, metabolic, endocrine, and inflammatory diseases, such as autoimmune and infectious diseases, as well as a history of malignant disease, were excluded. Those with acute cholecystitis or those who were morbidly obese (body mass index [BMI] > 25 kg/m²), had a history of smoking or alcohol consumption, and had used any drug with antioxidant properties within the previous 48 hours or lipid-lowering agents were also excluded. Demographic characteristics, including age, gender, weight, and height, as well as clinical data and the duration of anesthesia and operation, were recorded in all the patients. All the patients underwent routine clinical monitoring throughout the surgery, including electrocardiography and heart rate monitoring and noninvasive measurements of blood pressure, peripheral oxygen saturation (SpO₂), and ETCO₂ (Datex-Ohmeda and ADU, S/5, Helsinki, Finland). The patients were premedicated before the induction of anesthesia with midazolam 2 mg/kg. General anesthesia was administered using lidocaine 40 mg (Biologici Italia Laboratories, Milan, Italy), propofol 2 mg/kg (Propofol; Fresenius Kabi, Austria), and fentanyl 1–1.5 μg/kg (Abbott Laboratoires, Abbott Park, Illinois, USA). Endotracheal intubation was achieved after muscle relaxation by rocuronium 0.6 mg/kg (Rocuroniumbromür; Organon, Oss, Holland).

Anesthesia was maintained by 2-3% (1–1.5 MAC) sevoflurane in a 50%/50% (v/v) oxygen-air mixture. A fentanyl bolus (50 μg) was used if additional analgesia was required during the surgery. In addition, to maintain complete neuromuscular block, an additional rocuronium bolus (0.15 mg/kg) was given at 30 min intervals or when needed.

The patients’ lungs were mechanically ventilated with a volume-controlled ventilation mode using a lung-protective ventilation strategy (40% oxygen in air at a frequency of 10–12 breaths per min), and the tidal volume was adjusted to maintain an ETCO₂ level of 35–40 mmHg (VTffi: 8 mL/kg⁻¹; I : E ratio 1 : 2; PEEP: 4 cmH₂O; peak airway pressure: 15–20 cmH₂O) [6].

CO₂ pneumoperitoneum was performed by automatic insufflators (Karl Storz, Tuttlingen, Germany), and IAP of 10–12 mmHg was held at low speed (2 L/min) during the laparoscopic surgery.

The baseline peak inspiratory pressure (PIP), plateau pressure (PP), and ETCO₂ were measured, and the dynamic lung compliance (Cdyn) was calculated using the TV/PIP 10 min after the induction of anesthesia. All the measurements were then repeated 30 min after pneumoperitoneum in the LC group, 30 min after the skin incision in the AWH group, and at the end of the surgery before skin closure in both groups (after pneumoperitoneum in the LC group).

To analyze the total antioxidant status (TAS), total oxidant status (TOS), paraoxonase (PON1), arylesterase, glutathione peroxidase (GSH-Px), and malondialdehyde (MDA) levels, blood samples were drawn before the induction of anesthesia (baseline), 30 min after pneumoperitoneum in the LC group, 30 min after the incision in the AWH group (second blood samples), and at the end of the surgery before skin closure in both groups (third blood samples). Arterial blood gases were also analyzed at the same time as the blood samples.

Alveolar cells were obtained after anesthesia induction as a baseline and at the end of the surgery before extubation via the nonbronchoscopic blind bronchoalveolar lavage catheter technique described by Koksal et al. [7]. Heparinized blood and alveolar lavage samples were centrifuged at 1500 rpm for 10 min within 45 min after collection. The supernatant fluid was then transferred to Eppendorf tubes and immediately stored at −80°C until testing.

2.1. Measurement of MDA

MDA was measured in serum and BALF samples by the method described by Ohkawa et al. where the substrate reacts with thiobarbituric acid, and the results were expressed as nmol/L [8].

2.2. Measurement of GSH-Px

GSH-Px was measured in serum and BALF samples. Enzyme activities in BALF were expressed as U/L. GSH-Px activity was measured by the method of Paglia and Valentine [9]. Enzyme activities were expressed as U/L.

2.3. Measurement of Total Antioxidant Status

Serum TAS was determined using the novel automated measurement method by Erel, with commercially available kits (Rel Assay Diagnostic, Turkey). Antioxidants in the sample turned from dark blue-green colored ABTS radical to colorless reduced ABTS form. The change of absorbance at 660 nm denotes the total antioxidant level of the sample. The assay was calibrated with a stable antioxidant standard solution, Trolox Equivalent, which is a vitamin E analogue [10]. The results were expressed as mmol Trolox equivalent/L.

2.4. Measurement of Total Oxidant Status

Serum TOS was determined using the novel automated measurement method by Erel [11]. Oxidants present in the sample oxidize the ferrous ion-chelator complex to ferric ion. The oxidation reaction is prolonged by enhancer molecules, which are abundantly present in the reaction medium. The ferric ion makes a colored complex with chromogen in an acidic medium. The color intensity, which can be measured spectrophotometrically, is related to the total amount of oxidant molecules present in the sample. The assay is calibrated with hydrogen peroxide and the results are expressed in terms of the micromolar hydrogen peroxide equivalent per liter (μmol H₂O₂ Equiv./L).

2.5. Measurements of Paraoxonase and Arylesterase Activities

Paraoxonase and arylesterase activities were measured with commercially available kits (Rel Assay Diagnostic, Turkey). Fully automated paraoxonase activity measurement was performed either in the presence (salt-stimulated) or in the absence of NaCl. The paraoxon hydrolysis rate (diethyl-p-nitrophenyl phosphate) was measured by monitoring increased absorption at 412 nm at 37.8°C. The amount of generated p-nitrophenol was calculated from the molar absorption coefficient at pH 8.5, which was 18.290/M per cm. Paraoxonase activity was expressed as U/L serum. The coefficient of variation for individual samples was 1.8%. Serum arylesterase activity was determined by the presence of phenol following the reactions of phenylacetate. The molar extinction coefficient of phenol was 4,000 M⁻¹ cm⁻¹; the results were expressed as kU/L [12].

2.6. Statistical Analysis

All data were analyzed using SPSS (Statistical Package for the Social Science, version 14.0, SSPS Inc., Chicago, IL, USA) software. The Kolmogorov-Smirnov and Shapiro-Wilk tests were used as tests of normality, and Levene’s homogeneity of variance test was applied to all the variables. Significant statistical differences in the mean values of the variables between the groups were examined using Student’s -test or the Mann-Whitney test. A paired sample -test or Wilcoxon’s test was utilized for dependent variables. values less than 0.05 were considered statistically significant.

3. Results

There was no significant difference between the groups regarding demographic data, ASA classification, and duration of surgery and anesthesia (Table 1). Throughout the surgery, all the patients were hemodynamically stable in terms of heart rate, blood pressure, and SpO₂. Thus, none of the patients were excluded (data not shown).

Table 1: Clinical characteristics of the patients and operation-anesthesia durations of groups.

Laparoscopy group
Abdominal wall hernia group

Age (year)
42.61 ± 3.08
43.30 ± 2.61
0.414

Weight (kg)
66.91 ± 5.61
67.48 ± 5.88
0.741

Sex (female/male)
14/9
12/11
0.562

ASA I/II
13/10
11/12
0.565

Operation duration (min)
58.09 ± 2.57
58.61 ± 3.15
0.542

Anesthesia duration (min)
67.70 ± 2.81
68.78 ± 2.96
0.210

Data are expressed as mean ± standard deviation.

In LC group, there was a significant increase in the PIP, ETCO₂, and pCO₂ values (, , and , resp.), and there was a significant decrease in the Cdyn, pH, and pO₂ values at 30 min compared to baseline values (, , and , resp.) (Table 2).

Table 2: Pre- and perioperative levels of respiratory parameters and measurements of AKG in patients who underwent laparoscopic cholecystectomy and abdominal wall hernia.

Laparoscopy group
Abdominal wall hernia group

Baseline
30th minute
End of surgery
Baseline
30th minute
End of surgery

PIP
20 (16–32)
22 (19–33
20 (17–32)c
23 (20–27)
23 (18–28)
23 (20–28)

PLT
20 (11–33)
21 (10–36)
20 (12–33)
19 (15–27)
20 (14–27)
20 (15–25)

Cdyn
28.50 (22.72–38.55)
21.53 (17.30–29.41
28.50 (22.70–38.55)c
26.31 (20.50–35.61)
26.30 (20.53–35.62)
26.31 (20.52–35.60)

pO₂
202 (122–268)
125 (53–226
162 (110–250
185 (102–279)
189 (120–270)
185 (123–340)

pCO₂
38 (31–52)
45 (34–59
44 (27–60
41 (32–52)
39 (32–53)
40 (19–52)

pH
7.39 (7.31–7.49)
7.34 (7.24–7.50
7.35 (7.26–7.48
7.39 (7.33–7.44)
7.40 (7.29–7.46)
7.38 (7.30–7.55)

ETCO₂
31 (30–33)
35 (34–36
31 (30–32)c
31 (29–33)
32 (28–34)
31 (29–33)

Data are expressed as median (min–max).

Statistically significant differences ( < 0.05) were noted as follows: a; baseline versus 30th minute, b: baseline versus end of surgery, c; 30th versus end of surgery.

; Laparoscopy group versus abdominal wall hernia group.

PIP: peak in respiratory pressure, PLT: plateau pressure, Cdyn: dynamic lung compliance, ETCO₂: end-tidal CO₂.

The PIP, Cdyn, and ETCO₂ returned to baseline values at the end of the surgery, and these showed a significant difference compared to the values obtained during pneumoperitoneum (, , and , resp.). Changes observed in arterial blood gases persisted during this period. The pCO₂ values were increased and the pH values were decreased, and the differences were significant when compared to the baseline values ( and , resp.). The level of pO₂ was decreased, and this decrease was significant when compared to both the baseline and pneumoperitoneum periods ( and , resp.) (Table 2).

In the AWH group, no significant difference was observed in the PIP, Cdyn, ETCO₂, pH, pCO₂, and pO₂ values (). In addition, no significant difference was observed in the PP values in both groups () (Table 2).

In the LC group, the PIP and ETCO₂ values were significantly increased ( and , resp.), whereas the Cdyn values were significantly decreased when compared to the AWH group (). In the LC group, there was a significant decrease in the pH ( and , resp.) and pO₂ values ( and , resp.) and a significant increase in pCO₂ at 30 min and at the end of surgery when compared to the AWH group ( and , resp., Table 2).

In both groups, no significant difference was observed in the TAS levels between BALF samples obtained at the end of surgery and those obtained after induction (Figure 1(a)). In the LC group, a significant increase was observed in TOS, arylesterase, paraoxonase, and MDA levels (, , , and , resp.) at the end of surgery when compared to baseline values and those obtained after induction, whereas there was a significant decrease in GSH-Px levels () in the BALF samples (Figures 1(b), 2(a), 2(b), 3(a), and 3(b)). In the AWH group, similar changes were observed in TOS and arylesterase levels ( and , resp.), whereas no significant difference was observed in MDA, GSH-Px, and paraoxonase levels (Figures 1(b), 2(a), 2(b), 3(a), and 3(b)).

(a)

(b)

Figure 1: Pre- and perioperative TAS (total antioxidant status) (a) and TOS (total oxidant status) (b) levels of the groups in plasma and BALF. Data are expressed as mean ± standard error. compared to plasma baseline, compared to 30th minute, compared to BALF baseline, compared to BALF baseline.

(a)

(b)

Figure 2: Pre- and perioperative ARES (arylesterase) (a) and PON (paraoxonase) levels (b) levels of the groups in plasma and BALF. Data are expressed as mean ± standard error. compared to plasma baseline, compared to 30th minute, compared to BALF baseline, compared to BALF baseline, compared to plasma baseline, compared to laparoscopy versus abdominal wall hernia.

(a)

(b)

Figure 3: Pre- and perioperative MDA (malondialdehyde) (a) and GSH-Px (glutathione peroxidase) (b) levels of the groups in plasma and BALF. Data are expressed as mean ± standart error. compared to BALF baseline.

No significant difference was observed between the groups in TAS, TOS, paraoxonase, arylesterase, MDA, and GSH-Px levels in the BALF (Figures 1, 2, and 3).

There was no significant difference in the serum levels of TAS, MDA, and GSH-Px in the LC group (Figures 1(a), 3(a), and 3(b)). There was a significant increase in the TOS ( and , resp.) and paraoxonase ( and , resp.) in serum at the end of surgery compared to baseline and at 30 min (Figures 1(b) and 2(b)). There was also a significant increase in arylesterase levels at the end of surgery compared to baseline and at 30 min, in addition to 30 min compared to baseline values (, , and , resp.) (Figure 2(a)).

In the AWH group, no significant difference was observed in serum TAS, TOS, arylesterase, paraoxonase, MDA, and GSH-Px levels (Figures 1, 2, and 3). When the groups were compared, only serum paraoxonase levels at the end of surgery after deflation were increased in the LC group when compared to those of the AWH group () (Figure 2(b)).

4. Discussion

The results of our study showed that CO₂ pneumoperitoneum markedly increased PIP, pCO₂, and ETCO₂ levels and decreased Cdyn, pO2, and pH levels when compared to those of the AWH group. In the LC group, the increase in pCO₂ and the decrease in pO₂ and pH persisted, although all respiratory parameters returned to baseline values after deflation. The biochemical results for BALF and the serum samples supported the abovementioned effects.

Local-systemic inflammatory, endocrine-metabolic, and immunological responses observed in surgical procedures are associated with the volatile anesthetics used, mechanical ventilation, and surgical stress [13]. Patients undergoing laparoscopic cholecystectomy due to cholelithiasis are exposed to oxidative stress caused by pneumoperitoneum and the chronic pattern of the disease, in addition to the abovementioned effects of general anesthesia [14]. CO₂ pneumoperitoneum leads to several pathophysiological alterations in many systems. During laparoscopy, the most extensive changes are observed in the cardiovascular system. The changes observed during CO₂ pneumoperitoneum are mainly caused by hypercarbia, acidosis, and elevated IAP [5]. Acidosis caused by the direct effect of the CO₂ gas used plays a significant role in the intraoperative pulmonary inflammatory response to pneumoperitoneum. Hypercarbia and acidosis occur due to the passage of CO₂ with high solubility and peritoneal absorption [15]. In addition, impaired intrapulmonary distribution of CO₂ and decreased elimination of the gas occur due to increased intrathoracic pressure [4, 5, 16]. In general, respiratory acidosis is well tolerated by healthy individuals, and the blood pH is normalized by the buffering systems of body. This recycling can be challenging or occasionally impossible in patients with comorbid cardiorespiratory disease and in surgical procedures with prolonged periods of elevated IAP. Lower IAPs (10 mmHg) and shorter durations of pneumoperitoneum, as well as hyperventilation and sufficient PEEP support, can be beneficial in such patients. Open surgery should be considered if the abovementioned measures fail [5, 17].

Elevated IAP can also change respiratory mechanics. One study reported a decrease of 27% in respiratory system compliance and an increase of 35% in peak inspiratory pressure in cases where pneumoperitoneum was achieved with a pressure level of 15 mmHg [18]. These alterations return to normal control levels within 90 min after cessation of pneumoperitoneum. Laparoscopic cholecystectomy in the head-up tilt position is considered more appropriate for respiration. Moreover, alterations in compliance might be regulated swiftly after deflation in the head-up position rather than the head-down position [3]. Prolonged pneumoperitoneum can cause alterations in pulmonary compliance, which can take longer time to return to normal.

Ortiz-Oshiro et al. suggested that restriction of pressure by 12 mmHg and short surgery time are the most important factors to prevent potential oxidative injury in laparoscopic surgery [19].

In our study, IAP lower than 12 mmHg, which is clinically accepted, was used to provide adequate ventilation and oxygenation and to minimize respiratory changes. In addition, to prevent hypercapnia and acidosis during the surgery, the respiratory rate was adjusted, with the ETCO₂ being lower than 35 mmHg. By these measures, increased PIP and ETCO₂ levels and decreased Cdyn during pneumoperitoneum returned to baseline levels after cessation of pneumoperitoneum. However, the impairment in blood gases persisted.

Kazama et al. showed that CO₂ production increased by 50% and CO₂ elimination continued even after desufflation [20]. In another study, CO₂ levels returned to normal after deflation increased again 30 min after extubation [21].

The effects of elevated IAP due to pneumoperitoneum on the lung are not limited to the abovementioned factors. Normalization of blood flow by desufflation causes reperfusion in ischemic organs following ischemia due to a decrease in the blood flow of intra-abdominal organs by 10–80% during laparoscopy [22, 23]. Free oxygen radicals resulting from ischemia-reperfusion (I/R) injury due to laparoscopic procedures cause oxidative injury in distant organs, particularly lungs, other than splanchnic organs [24, 25]. There are a limited number of studies of the effects of pneumoperitoneum on the lungs, although numerous studies have investigated oxidative damage in intra-abdominal organs caused by pneumoperitoneum [7, 25, 26]. In these studies, there is no consensus on a valid marker of peroxidation or a method of determining oxidative stress, despite the use of several parameters of oxidative stress [2, 27].

In our study, increased TOS levels in BALF were detected in both groups as a result of mechanical ventilation and the volatile anesthetics used in general anesthesia, as well as surgical stress. High serum TOS levels indicating splanchnic ischemia caused by the increased IAP due to pneumoperitoneum persisted in systemic circulation during the reperfusion period after deflation. Moreover, in patients in the LC group, increased MDA levels in BALF and increased GSH-Px consumption were observed at the end of the surgery in patients in the LC group.

Free oxygen radicals, which are continuously produced as a result of aerobic metabolism, absorb H⁺ ions along lipid membranes. Lipid peroxidation products, which are produced by a number of reactions, lead to the formation of highly reactive aldehydes and damage membrane lipids. Measurement of MDA levels is the most important marker of free radical-mediated lipid peroxidation [28, 29]. Increased MDA levels due to ischemic damage in laparoscopic surgery have been demonstrated in many experimental and clinical trials [7, 30]. Glantzounis et al. reported that there was an increase in lipid peroxidation products and a decrease in endogenous antioxidants in the early postoperative period in laparoscopic surgery when compared to open cholecystectomy [31]. GSH-Px, one of the most important sources of antioxidant defense, plays a role in the removal of free oxygen radicals to protect the structure and function of biological membranes. In a rat model, Pross et al. found decreased GSH-Px levels accompanying marked lipid peroxidation in lungs during laparoscopy with CO₂ pneumoperitoneum when compared to laparoscopy without gas insufflation [26]. These authors reported that the oxidative stress contributed to impairment of pulmonary functions in laparoscopic procedures with CO₂ insufflation. In rats in which experimental pancreatitis was induced, Polat et al. detected increased MDA and decreased glutathione levels in rats that underwent laparoscopy with various pressure levels when compared to an open laparotomy group [32]. The authors suggested that laparoscopy increased the severity of pancreatitis. Our results support the presence of oxidative stress in the lung in the LC group.

Previous studies reported several biomarkers of decreased antioxidant enzyme levels, as well as compensatory and regulatory activity of antioxidants in oxidative stress [27, 33]. Some showed that the activity and the expression of paraoxonase with well-known antioxidant properties were decreased in oxidative stress [27, 34]. Paraoxonase, an ester hydrolase, exhibits dyazoxonase and Ca+2 dependent serum esterase activities, in addition to arylesterase and paraoxonase activities [35, 36]. It has been reported that paraoxonase activity is decreased in chronic inflammation, several diseases, and some cancer types [27, 37–39]. PON1 is helpful in monitoring the antioxidant defence system as well as TAS, TOS, MDA, and GSH-Px, in I/R injury [40, 41]. Yalcın et al. showed increased oxidant levels and decreased arylesterase activities in cholelithiasis, which is considered a chronic inflammatory process [14]. In our study, baseline serum paraoxonase and arylesterase levels were lower in the LC group compared to the AWH group. Therefore, the presence of cholelithiasis appears to have contributed to oxidative stress in the LC group by inducing inflammation through the production of reactive oxygen species.

In the perioperative period, the gradual increase in serum paraoxonase levels in the LC group compared to those in the AWH group has been attributed to a protective response to the early phase of oxidative damage caused by I/R injury. The increase is also thought to be associated with stimulation of the antioxidant defense system by increased oxidative stress. Uzar et al. reported that cerebral paraoxonase levels were increased in cerebral I/R injury [40]. Topsakal et al. reported increased paraoxonase levels in spinal cord injury [41]. Our results are in agreement with the literature.

The present study demonstrated clear effects of pneumoperitoneum in both serum and BALF oxidative parameters simultaneously with respiratory changes. In our study, acidosis and oxidative stress observed during pneumoperitoneum persisted following deflation at the end of the surgery in the laparoscopy group, although an IAP lower than 12 mmHg and a lung-protective ventilation strategy were used to prevent hypercapnia and acidosis. Undesirable effects of pneumoperitoneum on pulmonary functions can be tolerated in healthy individuals without development of hypoxemia or hypercapnia, whereas it can cause postoperative pulmonary complications in patients with comorbid pulmonary disease [5, 28].

Given the presence of chronic oxidative stress in patients with cholelithiasis, anesthesiologist should be aware of changes in respiratory dynamic and oxidative stress caused by pneumoperitoneum. In addition to the abovementioned measures, cardiovascular and pulmonary functions should be carefully monitored to prevent postoperative pulmonary complications, particularly in those with comorbid disease. Further studies are needed to develop novel anesthetic approaches and surgical techniques to control and limit pneumoperitoneum-related changes in pulmonary functions and oxidative stress.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

References

M. K. Suh, K. W. Seong, S. H. Jung, and S. S. Kim, “The effect of pneumoperitoneum and Trendelenburg position on respiratory mechanics during pelviscopic surgery,” Korean Journal of Anesthesiology, vol. 59, no. 5, pp. 329–334, 2010.

T. Sammour, A. Mittal, B. P. T. Loveday et al., “Systematic review of oxidative stress associated with pneumoperitoneum,” British Journal of Surgery, vol. 96, no. 8, pp. 836–850, 2009.

S. Odeberg-Wernerman, “Laparoscopic surgery—effects on circulatory and respiratory physiology: an overview,” European Journal of Surgery, vol. 165, no. 585, pp. 4–11, 2000.

T. Aran, M. A. Unsal, S. Guven, C. Kart, E. C. Cetin, and A. Alver, “Carbon dioxide pneumoperitoneum induces systemic oxidative stress: a clinical study,” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 161, no. 1, pp. 80–83, 2012.

C. N. Gutt, T. Oniu, A. Mehrabi et al., “Circulatory and respiratory complications of carbon dioxide insufflation,” Digestive Surgery, vol. 21, no. 2, pp. 95–105, 2004.

G. M. Koksal, C. Sayilgan, G. Gungor et al., “Effects of sevoflurane and desflurane on cytokine response during tympanoplasty surgery,” Acta Anaesthesiologica Scandinavica, vol. 49, no. 6, pp. 835–839, 2005.

G. M. Koksal, C. Sayilgan, S. Aydin, H. Uzun, and H. Oz, “The effects of sevoflurane and desflurane on lipid peroxidation during laparoscopic cholecystectomy,” European Journal of Anaesthesiology, vol. 21, no. 3, pp. 217–220, 2004.

H. Ohkawa, N. Ohishi, and K. Yagi, “Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction,” Analytical Biochemistry, vol. 95, no. 2, pp. 351–358, 1979.

D. E. Paglia and W. N. Valentine, “Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase,” The Journal of Laboratory and Clinical Medicine, vol. 70, no. 1, pp. 158–169, 1967.

O. Erel, “A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation,” Clinical Biochemistry, vol. 37, no. 4, pp. 277–285, 2004.

O. Erel, “A new automated colorimetric method for measuring total oxidant status,” Clinical Biochemistry, vol. 38, no. 12, pp. 1103–1111, 2005.

Z. Suchocka, J. Swatowska, J. Pachecka, and P. Suchocki, “RP-HPLC determination of paraoxonase 3 activity in human blood serum,” Journal of Pharmaceutical and Biomedical Analysis, vol. 42, no. 1, pp. 113–119, 2006.

B. Kücükakin, M. Klein, J. Lykkesfeldt, R. J. Reiter, J. Rosenberg, and I. Gögenur, “No effect of melatonin on oxidative stress after laparoscopic cholecystectomy: a randomized placebo-controlled trial,” Acta Anaesthesiologica Scandinavica, vol. 54, no. 9, pp. 1121–1127, 2010.

S. Yalcın, H. Aydogan, H. Serdaroglu et al., “Impact of volatile anesthetics on oxidative stress in patients undergoing laparoscopic cholecystectomy for gallstones,” Turkiye Klinikleri Journal of Medical Sciences, vol. 32, pp. 112–119, 2012.

C.-H. Hsieh, “Laparoscopic cholecystectomy for patients with chronic obstructive pulmonary disease,” Journal of Laparoendoscopic & Advanced Surgical Techniques A, vol. 13, no. 1, pp. 5–9, 2003.

E. Karagulle, E. Turk, R. Dogan, Z. Ekici, R. Dogan, and G. Moray, “The effects of different abdominal pressures on pulmonary function test results in laparoscopic cholecystectomy,” Surgical Laparoscopy, Endoscopy and Percutaneous Techniques, vol. 18, no. 4, pp. 329–333, 2008.

K. C. Sharma, G. Kabinoff, Y. Ducheine, J. Tierney, and R. D. Brandstetter, “Laparoscopic surgery and its potential for medical complications,” Heart and Lung: Journal of Acute and Critical Care, vol. 26, no. 1, pp. 52–67, 1997.

R. Rauh, T. M. Hemmerling, M. Rist, and K. E. Jacobi, “Influence of pneumoperitoneum and patient positioning on respiratory system compliance,” Journal of Clinical Anesthesia, vol. 13, no. 5, pp. 361–365, 2001.

E. Ortiz-Oshiro, J. Mayol, J. C. Aparicio Medrano, M. A. Sanjuan Garcia, and J. Alvarez Fernández-Represa, “Lactate metabolism during laparoscopic cholecystectomy: comparison between CO₂ pneumoperitoneum and abdominal wall retraction,” World Journal of Surgery, vol. 25, no. 8, pp. 980–984, 2001.

T. Kazama, K. Ikeda, T. Kato, and M. Kikura, “Carbon dioxide output in laparoscopic cholecystectomy,” British Journal of Anaesthesia, vol. 76, no. 4, pp. 530–535, 1996.

H. Iwasaka, H. Miyakawa, H. Yamamoto, T. Kitano, K. Taniguchi, and N. Honda, “Respiratory mechanics and arterial blood gases during and after laparoscopic cholecystectomy,” Canadian Journal of Anaesthesia, vol. 43, no. 2, pp. 129–133, 1996.

M. Schäfer and L. Krähenbühl, “Effect of laparoscopy on intra-abdominal blood flow,” Surgery, vol. 129, no. 4, pp. 385–389, 2001.

M. A. Unsal, M. Imamoglu, M. Kadioglu et al., “The acute alterations in biochemistry, morphology, and contractility of rat-isolated terminal ileum via increased intra-abdominal pressure,” Pharmacological Research, vol. 53, no. 2, pp. 135–141, 2006.

A. Akyol, H. Ulusoy, M. Imamoglu et al., “Does propofol or caffeic acid phenethyl ester prevent lung injury after hindlimb ischaemia-reperfusion in ventilated rats?” Injury, vol. 37, no. 5, pp. 380–387, 2006.

S. Karapolat, S. Gezer, U. Yildirim et al., “Prevention of pulmonary complications of pneumoperitoneum in rats,” Journal of Cardiothoracic Surgery, vol. 6, no. 1, article 4, 2011.

M. Pross, H. U. Schulz, A. Flechsig et al., “Oxidative stress in lung tissue induced by CO₂ pneumoperitoneum in the rat,” Surgical Endoscopy, vol. 14, no. 12, pp. 1180–1184, 2000.

H. Koksal and S. Kurban, “Total oxidant status, total antioxidant status, and paraoxonase and arylesterase activities during laparoscopic cholecystectomy,” Clinics, vol. 65, no. 3, pp. 285–290, 2010.

B. Zulfikaroglu, M. Koc, A. Soran, F. K. Isman, and I. Cinel, “Evaluation of oxidative stress in laparoscopic cholecystectomy,” Surgery Today, vol. 32, no. 10, pp. 869–874, 2002.

N. Kotani, H. Hashimoto, D. I. Sessler et al., “Expression of genes for proinflammatory cytokines in alveolar macrophages during propofol and isoflurane anesthesia,” Anesthesia and Analgesia, vol. 89, no. 5, pp. 1250–1256, 1999.

E. Eleftheriadis, K. Kotzampassi, K. Papanotas, N. Heliadis, and K. Sarris, “Gut ischemia, oxidative stress, and bacterial translocation in elevated abdominal pressure in rats,” World Journal of Surgery, vol. 20, no. 1, pp. 11–16, 1996.

G. K. Glantzounis, A. D. Tselepis, A. P. Tambaki et al., “Laparoscopic surgery-induced changes in oxidative stress markers in human plasma,” Surgical Endoscopy, vol. 15, no. 11, pp. 1315–1319, 2001.

C. Polat, H. Uyar, I. Bassorgun et al., “Laparoscopy can aggravate the severity of pancreatitis in an experimental rat model,” Journal of Laparoendoscopic & Advanced Surgical Techniques A, vol. 22, no. 10, pp. 978–983, 2012.

J. Lantos, E. Röth, L. Czopf, J. Nemes, and I. Gál, “Monitoring of plasma total antioxidant status in different diseases,” Acta chirurgica Hungarica, vol. 36, no. 1–4, pp. 188–189, 1997.

M. Aviram, M. Rosenblat, S. Billecke et al., “Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants,” Free Radical Biology and Medicine, vol. 26, no. 7-8, pp. 892–904, 1999.

B. Mackness, P. N. Durrington, and M. I. Mackness, “Human serum paraoxonase,” General Pharmacology, vol. 31, no. 3, pp. 329–336, 1998.

A. Canales and F. J. Sánchez-Muniz, “Paraoxonase, something more than an enzyme?” Medicina Clinica, vol. 121, no. 14, pp. 537–548, 2003.

M. Gur, M. Aslan, A. Yildiz et al., “Paraoxonase and arylesterase activities in coronary artery disease,” European Journal of Clinical Investigation, vol. 36, no. 11, pp. 779–787, 2006.

M. Krzystek-Korpacka, D. Boehm, M. Matusiewicz, D. Diakowska, K. Grabowski, and A. Gamian, “Paraoxonase 1 (PON1) status in gastroesophageal malignancies and associated paraneoplastic syndromes—connection with inflammation,” Clinical Biochemistry, vol. 41, no. 10-11, pp. 804–811, 2008.

E. T. Elkiran, N. Mar, B. Aygen, F. Gursu, A. Karaoglu, and S. Koca, “Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population,” BMC Cancer, vol. 7, article 48, 2007.

E. Uzar, A. Acar, O. Evliyaoglu et al., “The anti-oxidant and anti-apoptotic effects of nebivolol and zofenopril in a model of cerebral ischemia/reperfusion in rats,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 36, no. 1, pp. 22–28, 2012.

C. Topsakal, N. Kilic, F. S. Erol et al., “Medroxyprogesterone acetate, enoxaparin and pentoxyfylline cause alterations in lipid peroxidation, paraoxonase (PON1) activities and homocysteine levels in the acute oxidative stress in an experimental model of spinal cord injury,” Acta Neurochirurgica, vol. 144, no. 10, pp. 1021–1031, 2002.